Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPTLC1P3 is a pseudogene related to the gene encoding serine palmitoyltransferase long chain base subunit 1 (SPTLC1). Pseudogenes such as SPTLC1P3 are DNA sequences similar to functional genes but generally lack the ability to encode a functional protein due to accumulated mutations or incomplete sequences. SPTLC1P3 is not known to have a biological function, is not a recognized therapeutic target, and is not associated with human disease or drug response. Its full gene symbol is "serine palmitoyltransferase long chain base subunit 1 pseudogene 3," and it is annotated in gene databases purely for genomic completeness rather than functional relevance[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine palmitoyltransferase long chain base subunit 1 pseudogene 3 (SPTLC1P3).